G E N E R A L I N T R O D U C T I O N 27. Michalik L, Desvergne B, et al. Impaired skin wound healing in peroxisome proliferator-‐activated receptor (PPAR)α and PPARβ mutant mice. J Cell Biol 2001; 154:799–814. 28. Boza JC, Trindade EN, et al. Skin manifestations of obesity; a comparative study. J Eur Acad Dermatol Venereol 2012; 26(10):1220-‐1223. 29. Davidivici BB, Sattar N et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-‐morbid conditions. J Invest Dermatol 2010; 130:1785-‐1796. 30. Kim N, Thrash B et al. Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010; 29:10-‐15. 31. Hercogova J, Ricceri F et al. Psoriasis and body mass index. Dermatol Ther 2010; 23: 152-‐154. 32. Wolk K, Mallbris L et al. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89:492-‐497. 33. Menter A, Griffiths CE et al. International Psoriasis Council. Exploring the association between cardi-‐ ovascular and other disease-‐related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol 2010; 24:1371-‐1377. 34. Prey S, Paul C et al. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24:23-‐30. 35. Roth CL, Sathyanarayana S. Mechanisms affecting neuroendocrine and epigenetic regulation of body weight and onset of puberty: potential implications in the child born small for gestational age (SGA) Rev Endoc Metab Disord 2012; 13(2):129-‐40. 36. Bradley TJ, Potts JE et al. Early changes in the biophysical properties of the aorta in pre-‐adolescent children born small for gestational age. J Pediatr. 2010; 156:388-‐92. 37. Boersma B, Wit JM. Catch-‐up growth. Endocr Rev. 1997; 18:646-‐61. 38. Bavdekar A, Yajnik CS et al. Insulin resistance syndrome in 8 year old Indian children: small at birth, big at 8 years, or both? Diabetes 1999; 48:2422-‐9. 39. Veening MA, Van Weissenbruch MM et al. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab. 2002; 87:4657-‐61. 40. Hassan HM, Kohno H, et al. Body composition, atherogenic risk factors and apolipoproteins follow-‐ ing growth hormone treatment. Acta Paediatr 1996; 85:899-‐901. 41. Cowan FJ, Evas WD, et al. Metabolic effects of discontinuing growth hormone treatment. Arch Dis Child 1999; 80:517-‐523. 42. Gregory JW, Greene SA, et al. Changes in body composition and energy expenditure after six weeks’ growth hormone treatment. Arch Dis Child 1991; 66:598-‐602. 43. Dempsher DP, Bier DM, et al. Whole body nitrogen kinetics and their relationship to growth in short children treated with recombinant human growth hormone. Pediatr Res 1990; 28:394-‐400. 44. Rasmussen MH, Obesity, growth hormone and weight loss, Mol Cell Endocrinol. 2010; 25 316(2):147-‐53. 45. Gerver WJM. de Bruin R. Paediatric Morphometrics, A reference manual. (second extended edition). University Press Maastricht, The Netherlands, ISBN 90 5278 307 1; 2001. 21
Proefschrift binnenwerk Manon Ernst_DEF.indd
To see the actual publication please follow the link above